FGFR3 and Alzheimer disease: In this context, STZ conferred most of the features of AD, with progressive deficits in learning, memory, and cognitive behavior, along with aggregation of Aβ and neuron loss in the cortex and hippocampus, and a massive reduction in hippocampal Ach level, in line with former studies [26, 43, 44].